Literature DB >> 12450664

Advanced analytical methods for hemoglobin variants.

Yoshinao Wada1.   

Abstract

Hemoglobin variants are the protein mutations most often encountered in the clinical scene. They have been useful for developing methods to analyze mutant proteins because of their size and ease of collection in large amounts. Improvements in analytical methods have been directed toward higher resolution in electrophoresis and shorter elution times in chromatography. More importantly, in the last 20 years, hemoglobin variants have been used in the development of mass spectrometric strategies for analyzing protein mutations. This approach consists of a series of steps: measurement of the molecular mass of globins to detect or confirm the presence of mutations, peptide mass mapping or peptide mass fingerprinting of an enzymatic digest to identify mutated peptides, and tandem mass spectrometry to determine or confirm the site and type of mutation. The mass spectrometric strategy has enabled rapid analysis and demonstrated a superb ability to detect a number of hemoglobin variants, particularly those without a change in electrophoretic or chromatographic properties. Even with the recent advances in DNA analysis, protein analysis is still essential, because post-translational modifications following amino acid substitutions can occur including N-terminal acetylation, deamidation and oxidation-mediated processes.

Mesh:

Substances:

Year:  2002        PMID: 12450664     DOI: 10.1016/s1570-0232(02)00558-5

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Analyses of in vitro nonenzymatic glycation of normal and variant hemoglobins by MALDI-TOF mass spectrometry.

Authors:  Bao-Shiang Lee; G D Lasanthi P Jayathilaka; Jin-Sheng Huang; Loyda N Vida; George R Honig; Shalini Gupta
Journal:  J Biomol Tech       Date:  2011-09

2.  Determination of unique amino acid substitutions in protein variants by peptide mass mapping with FT-ICR MS.

Authors:  Katsuhiro Tanaka; Shigeo Takenaka; Shingo Tsuyama; Yoshinao Wada
Journal:  J Am Soc Mass Spectrom       Date:  2006-02-20       Impact factor: 3.109

3.  Identification of a Rare Hemoglobin Variant HbJ-Rajappen [alpha90 (FG2) Lys → Thr] Using Mass Spectrometry.

Authors:  Vijay S Bhat; Amit Kumar Mandal; Bobby Mathew
Journal:  Indian J Clin Biochem       Date:  2012-03-24

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Characterization of a hemoglobin variant: HbQ-India / IVS 1-1 [G>T]-β-thalassemia.

Authors:  Vijay S Bhat; K K Dewan; P R Krishnaswamy; A K Mandal; P Balaram
Journal:  Indian J Clin Biochem       Date:  2010-02-10

6.  Rapid separation of human globin chains in normal and thalassemia patients by RP-HPLC.

Authors:  Hooshang Nemati; Gholamreza Bahrami; Zohreh Rahimi
Journal:  Mol Biol Rep       Date:  2010-03-05       Impact factor: 2.316

7.  Capillary hemoglobin electrophoresis of healthy and anemic dogs: Quantification, validation, and reference intervals of hemoglobin fractions.

Authors:  Ioannis L Oikonomidis; Theodora K Tsouloufi; Mathios E Mylonakis; Maria Kritsepi-Konstantinou
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.